Skip to main content

Table 5 Relation of the FIB level and all-cause death in patients with different glycemic metabolism status

From: Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study

Variables

Events/subjects

HR (95% CI)

214/6140

Crude model

Adjusted model

NG

 FIB-L

7/537

Reference

Reference

 FIB-M

13/433

2.35 (0.94–5.87)

2.08 (0.83–5.22)

 FIB-H

14/424

2.62 (1.06–6.49) *

1.96 (0.79–4.89)

Pre-DM

 FIB-L

21/1011

1.59 (0.68–3.74)

1.24 (0.53–2.93)

 FIB-M

33/944

2.73 (1.21–6.12) *

2.17 (0.96–4.93)

 FIB-H

40/929

3.40 (1.52–7.58) **

2.27 (1.01–5.12) *

DM

 FIB-L

15/521

2.23 (0.91–5.46)

1.67 (0.68–4.10)

 FIB-M

29/656

3.45 (1.51–7.89) **

2.57 (1.12–5.89) *

 FIB-H

42/685

4.91 (2.20–10.92) **

3.04 (1.35–6.82) **

  1. Model adjusted for age, sex, BMI, hypertension, diabetes, family history of CAD, prior PCI/CABG, LVEF, LDL-C, creatine, DES implantation, clopidogrel, ACEI/ARB
  2. CI confidence interval, FIB fibrinogen, NG normoglycemia, Pre-DM prediabetes, DM diabetes mellitus
  3. * P value < 0.05, ** P value < 0.01